Relay Therapeutics, Inc.
Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: RLAY
Relay Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker RLAY. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2024.
Relay Therapeutics at a glance
What does Relay Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $30 million sold (2024).
Frequently asked questions about Relay Therapeutics
Where is Relay Therapeutics headquartered?
Relay Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Relay Therapeutics do?
Relay Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Relay Therapeutics a public company?
Yes. Relay Therapeutics, Inc. trades on Nasdaq under the ticker RLAY.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Epicore Biosystems, Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.